Edwards Lifesciences Corp (NYSE:EW)
| 125.35 Data as of Jan 30 |  -3.93 / -3.04%Today’s Change | 63.04 Today|||52-Week Range 137.19 | -1.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2013 | Quarter 1 2014 | Quarter 2 2014 | Quarter 3 2014 | |||
| Operating Activities | Net Income / Starting Line | 75.8M | 60.3M | 547.0M | 94.6M | |
| Depreciation | 18.8M | 16.2M | 16.1M | 18.0M | ||
| Total Other Cash Flow | 16.7M | 8.4M | 3.0M | -2.0M | ||
| Funds From Operations | 110.0M | 85.6M | 567.4M | 110.8M | ||
| Funds From/For Other Operating Expenses | -1.3M | -53.3M | -210.6M | 98.6M | ||
| Net Cash Flow - Operating Activities | 111.3M | 138.9M | 778.0M | 12.2M | ||
| Investing | Increase In Investments | -451.6M | -402.9M | -754.5M | -454.4M | |
| Decrease In Investments | 223.9M | 296.8M | 299.4M | 317.4M | ||
| Capital Expenditures | -20.1M | -14.3M | -16.0M | -18.1M | ||
| Fixed Asset Disposal | 1.3M | -- | -- | -- | ||
| Other Investing - Uses | 100.0K | 0.00 | 0.00 | 0.00 | ||
| Other Investing - Sources | -- | 600.0K | 700.0K | 300.0K | ||
| Net Cash Flow Investing | -246.9M | -119.8M | -470.4M | -154.8M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 599.9M | 208.3M | 5.8M | 6.2M | ||
| Long Term Debt Reduction | -535.6M | -78.3M | -134.6M | -6.1M | ||
| Net Proceeds Stock Sale | 8.6M | 14.2M | 18.7M | 38.4M | ||
| Common Preferred Redeemed | -22.7M | -300.0M | -600.0K | -100.0K | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 7.6M | 14.0M | 7.3M | 12.9M | ||
| Other Uses - Financing | -22.7M | 2.0M | 400.0K | 2.6M | ||
| Net Cash Flow - Financing | 80.5M | -143.8M | -103.8M | 48.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 4.5M | 0.00 | -900.0K | -600.0K | |
| Net Change In Cash | -55.1M | -124.7M | 203.8M | -93.9M | ||
.